The WACC of Zentalis Pharmaceuticals Inc (ZNTL) is 8.8%.
| Range | Selected | |
| Cost of equity | 10.90% - 14.50% | 12.70% |
| Tax rate | 0.20% - 0.20% | 0.20% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 7.9% - 9.7% | 8.8% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 1.52 | 1.72 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 10.90% | 14.50% |
| Tax rate | 0.20% | 0.20% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 7.9% | 9.7% |
| Selected WACC | 8.8% | |